Several organs (lung, skin, thyroid, heart, bone marrow) (British Joumnal ofIndustrial Medicine 1993;50:835-842) 
(eczema, erythema) than control workers. Within the exposed group a dose-effect relation was found between the reduction of the forced expiratory volume in one secondivital capacity and the intensity of current exposure to Co assessed by the measurement of Co in air or in urine. The prevalence of dyspnoea was related to the dustiness of the workplace as reflected by a statistically significant logistic regression between this symptom and the current levels of Co in air and in urine. No difference between lung volumes, ventilatory performances, carbon monoxide diffusing capacity, and serum myocardial creatine kinase and procollagen III peptide was found between the Co and control groups and no lung abnormalities were detected on the chest radiographs in both groups. The results suggest that exposure to high airborne concentrations of Co alone is not sufficient to cause pulmonary fibrosis. This finding is compatible with experimental studies indicating that interaction of other airborne pollutants with Co particles play a part in the pathogenesis of parenchymal lung lesions. (British Joumnal ofIndustrial Medicine 1993; 50:835-842) Excessive exposure to Co compounds has been associated with adverse effects in several organs (skin, lung, thyroid gland, myocardium, bone marrow). In occupational settings, the respiratory tract is the main target organ.1
There is ample evidence that exposure to Co dust, alone or in association with other substances, may cause bronchial asthma.2-5 The symptoms (wheezing, chest tightness, dyspnoea, cough) usually improve after removal from exposure. A type I allergic reaction has been postulated, because specific IgE antibodies against a complex of Co with albumin can sometimes be detected. 6 This, however, does not exclude a non-specific irritative action of Co on the bronchial tree. 3 The incidence of bronchial asthma induced by Co is low (5%).
Another pulmonary disease, also associated with exposure to dust containing Co, is the so called "hard metal disease", an interstitial lung disease ranging from alveolitis to pulmonary fibrosis. It has the typical clinical features of a progressive interstitial lung disease: dry cough, dyspnoea during exercise and subsequently at rest, weight loss, and cyanosis. In the later stages cor pulmonale may develop. Lung function tests reveal reduced lung volumes and diffusing capacity. Chest radiographs often show fine or course linear and/or round opacities.3 4 7-10 Since the first report by Jobs and Ballhausen in 1940,1" it has often been questioned whether Co alone is responsible for this particular disease. '2 Several animal experiments with Co metal and salts have failed to reproduce the typical pulmonary lesions found in humans. [13] [14] [15] It is also important to note that most cases of interstitial disease were described in hard metal and diamond polishing industries, where workers are exposed not only to Co metal powder but also to other constituents such as tungsten carbide, titanium carbide, diamond particles etc.2 3 9 16-19 The few studies so far carried out in Co refineries, where exposure is to pure Co dust, never identified typical cases of interstitial disease.20 21 Therefore, to evaluate whether exposure to pure Co dust may lead to adverse health effects, a cross sectional health survey was carried out in a Co refinery in Belgium. At the same time, an environmental and biological monitoring programme was set up to characterise exposure to Co.
Subjects and methods

STUDY POPULATION
The Co plant, which is part of a large metallurgical concern, uses a wide variety of raw materials, main- Total T3, T4, TSH, and T3 uptake were analysed by radioimmunoassay with the kits purchased from Monobind (Costa Mesa, CA, USA).
Myocardial creatine kinase (CPK) activity in serum was determined with the CK-MB (NACact) Monotest from Boehringer Diagnostica (Mannheim, Germany). The procollagen III peptide (PC-III-P) was determined with the radioimmunoassay-gnost P-III-P from Behringwerke AG (Marburg, Germany). The concentrations of Co in whole blood and in urine were determined by flameless atomic absorption spectrometry with a Perkin-Elmer 5000 Zeeman spectrometer. Urinary workshift and the week, the relative changes in concentrations were less than for urine. Concentrations of Co in urine (postshift sample) and in blood were correlated with Co in air both on Monday and on Friday (r = 0-72 and 0-61 for urine and r = 0-64 and 0-60 for blood respectively p < 0 001). In control workers all the results of Co in urine and Co in blood were below 2 ,ug/g creatinine and 0-2 ,ug/dl respectively. A few determinations of Co in air were performed in the control plant. All the results were below 005 ,ug/m3 confirming the absence of exposure to Co in the control group. Values are numbers of workers (%).
Epidemiological survey ofworkers exposed to cobalt oxides, cobalt salts, and cobalt metal 
Discussion
The present cross sectional epidemiological study compared male workers exposed to Co metal, Co oxides, and Co salts with a well matched control group. The workers were exposed for 8-0 years on average (range 0-3-39-4) to a mean airborne Co concentration of 125 1Ig/m3 but for about 25% of the workers, the TWA exceeded 500 ,ug/m3. Exposure to Co was clearly reflected by an increase in the concentration of Co in urine at the end of the workshift. Although selection bias (healthy worker effect) cannot be formally excluded in the framework of a cross sectional study, it is unlikely that it may significantly affect our estimate because of the stability of the workforce in both plants. A This view is supported by recent in vitro and in vivo experimental studies32-35 performed in our laboratory which show that the biological reactivity of Co-tungsten carbide mixture is much greater than that of Co metal particles alone. The bioavailability of Co is also enhanced in the presence of tungsten carbide. For example, a tungsten carbide-Co mixture as prepared by the hard metal industry was almost as toxic towards rat alveolar macrophages as crystalline silica whereas pure tungsten carbide had no effect and pure Co metal powder only slightly impaired cell viability. The uptake of Co by macrophages was also increased in the presence of tungsten carbide.32 In rats, the intratracheal instillation of a tungsten carbide-Co mixture (16-67 mg/l00 g body weight corresponding to 1-0 mg Co/100 g) caused a severe alveolitis and fatal pulmonary edema whereas the corresponding dose of Co powder alone only caused a moderate inflammatory response. 35 Preliminary results also indicate that the delayed fibrotic reaction is only seen after administration of the tungsten carbide Co mixture. The amount of Co excreted in urine was also significantly higher when the animals were exposed to this mixture than to an equivalent amount of pure Co particles, confirming the increased bioavailability of Co metal when combined with tungsten carbide.
These experimental data may explain why parenchymal lesions are rarely, if ever, seen in workers exposed to pure Co dust. The simultaneous inhalation of other compounds such as tungsten carbide seems a necessary condition to induce a severe alveolitis leading to lung fibrosis. This sug-gests that acceptable exposure to the metal might have to vary depending on whether exposure is to Co alone or to a combination of Co 
